Chronotherapeutically Modulated Pulsatile System of Valsartan Nanocrystals—an In Vitro and In Vivo Evaluation

No abstract is available for this paper.

• Publication year

  2016

• Venue

  AAPS PharmSciTech

• Publication date

  2016-03-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1208/s12249-016-0511-5PMID 26961969
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development and optimization of press coated tablets of release engineered valsartan for pulsatile delivery

  2015cited by this paper
• Pulsatile core-in-cup valsartan tablet formulations: In vitro evaluation

  2013cited by this paper
• Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.

  2012cited by this paper
• Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization.

  2012cited by this paper
• Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.

  2012cited by this paper
• Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change

  2011cited by this paper
• Preparation and antitumor study of camptothecin nanocrystals.

  2011cited by this paper
• Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.

  2010cited by this paper
• Improved pH-independent dissolution and oral absorption of valsartan via the preparation of solid dispersion

  2010cited by this paper
• Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.

  2010cited by this paper
• Understanding the structure and stability of paclitaxel nanocrystals.

  2010cited by this paper
• Chronotherapeutic drug delivery for early morning surge in blood pressure: a programmable delivery system.

  2009cited by this paper
• Effect of maltodextrin and superdisintegrant in directly compressible powder mixtures prepared via co-spray drying.

  2008cited by this paper
• Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.

  2008cited by this paper
• Preparation and Characterization of an Oridonin Nanosuspension for Solubility and Dissolution Velocity Enhancement

  2007cited by this paper
• Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals.

  2007cited by this paper
• Improvement of Solubility and Stability of Valsartan by Hydroxypropyl-\boldbeta-Cyclodextrin

  2006cited by this paper
• Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs.

  2006cited by this paper
• Effect of ultrasound on anti-solvent crystallization process

  2005cited by this paper
• Administration Time‐Dependent Effects of Valsartan on Ambulatory Blood Pressure in Elderly Hypertensive Subjects

  2005cited by this paper
• Harrison's Principles of Internal Medicine 16th Edition

  2004cited by this paper
• Processing of Spherical Crystalline Particles via a Novel Solution Atomization and Crystallization by Sonication (SAXS) Technique

  2004cited by this paper
• Nanosuspensions in drug delivery

  2004cited by this paper
• Exploiting M cells for drug and vaccine delivery.

  2001cited by this paper
• In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.

  2000cited by this paper
• [Compliance and the chronotherapy of refractory arterial hypertension].

  1997cited by this paper
• Valsartan. A review of its pharmacology and therapeutic use in essential hypertension.

  1997cited by this paper
• [The treatability of refractory or resistant hypertension by personalized antihypertensive chronotherapy based on ambulatory monitoring of the arterial pressure].

  1996cited by this paper
• Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs

  1995cited by this paper
• Harrison's Principles of Internal Medicine

  1988cited by this paper
• The rate of solution of solid substances in their own solutions

  1897cited by this paper

• Recent developments in the use of nanocrystals to improve bioavailability of APIs.

  2024cites this paper
• pH-dependent pulsatile delivery of Ambrisentan for the treatment of hypertension

  2023influential citation
• Nanotechnology‐Based Strategies for Extended‐Release Delivery of Angiotensin Receptor Blockers (ARBs): A Comprehensive Review

  2023cites this paper
• Antihypertensives’ Rock around the Clock

  2021cites this paper
• Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension

  2021cites this paper
• Modification of valsartan drug release by incorporation into sericin/alginate blend using experimental design methodology

  2021cites this paper
• Preparation and appraisal of self-assembled valsartan-loaded amalgamated Pluronic F127/Tween 80 polymeric micelles: Boosted cardioprotection via regulation of Mhrt/Nrf2 and Trx1 pathways in cisplatin-induced cardiotoxicity

  2020cites this paper
• Preparation of in situ hydrogels loaded with azelaic acid nanocrystals and their dermal application performance study

  2019cites this paper
• DEVELOPMENT AND EVALUATION OF VALSARTAN ORAL CONTROLLED RELEASE FORMULATIONS

  2018cites this paper
• Chronotherapy for Hypertension

  2018cites this paper
• Systems Chronotherapeutics

  2017cites this paper
• Spray-dried nanocrystals for a highly hydrophobic drug: Increased drug loading, enhanced redispersity, and improved oral bioavailability.

  2017cites this paper
• Surface modification of docetaxel nanocrystals with HER2 antibody to enhance cell growth inhibition in breast cancer cells.

  2017cites this paper
• Mucoadhesive biphasic minitablets of cefuroxime axetil: Formulation development, characterization and in vivo bioavailability study

  2016cites this paper
• Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting

  2016cites this paper